Roberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, Dario Arnaldi, Vincenzo Belcastro, Simone Beretta, Giovanni Boero, Paolo Bonanni, Laura Canafoglia, Alfredo D'Aniello, Filippo Dainese, Carmen De Caro, Giancarlo Di Gennaro, Roberta Di Giacomo, Jacopo C DiFrancesco, Fedele Dono, Giovanni Falcicchio, Edoardo Ferlazzo, Nicoletta Foschi, Silvia Franciotta, Antonio Gambardella, Alfonso Giordano, Luigi Francesco Iannone, Angelo Labate, Angela La Neve, Simona Lattanzi, Ugo Leggio, Claudio Liguori, Marta Maschio, Annacarmen Nilo, Francesca Felicia Operto, Angelo Pascarella, Giada Pauletto, Rosaria Renna, Gionata Strigaro, Emilio Russo
OBJECTIVE: There is little comparative data on the third-generation antiseizure medications (ASMs). We aimed to assess and compare the effectiveness of brivaracetam (BRV), eslicarbazepine acetate (ESL), lacosamide (LCM) and perampanel (PER) in people with epilepsy (PWE). Efficacy and tolerability were compared as secondary objectives. METHODS: A multicenter, retrospective study collecting data from 22 Italian neurology/epilepsy centres. All adult PWE who started add-on treatment with one of the studied ASMs between January 2018 and October 2021 were included...
December 5, 2023: Epilepsia